GH
Greg Harrison BofA Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
73
Avg Return
Past Year
Past Year
8.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Buy
72.7%
Hold
27.3%
Sell
0%
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
United Therapeutics
UTHR
$19.9B
|
Hold
Maintained
| $463 |
5%
upside
| 1 | – |
–
| 2 Sep ‘25 1 month ago |
|
Mineralys Therapeutics
MLYS
$3.27B
|
Buy
Maintained
| $43 |
2%
upside
| 1 | +177% |
0
%
| 28 Aug ‘25 1 month ago |
|
Travere Therapeutics
TVTX
$2.24B
|
Buy
Maintained
| $31 |
23%
upside
| 1 | +13% |
0
%
| 7 Aug ‘25 2 months ago |
|
Ocular Therapeutix
OCUL
$2.5B
|
Buy
Maintained
| $20 |
70%
upside
| 1 | +7.7% |
0
%
| 6 Aug ‘25 2 months ago |
|
BridgeBio Pharma
BBIO
$10.6B
|
Buy
Maintained
| $57 |
3%
upside
| 1 | +13% |
0
%
| 6 Aug ‘25 2 months ago |
|
Vertex Pharmaceuticals
VRTX
$105B
|
Hold
Maintained
| $438 |
7%
upside
| 1 | – |
–
| 5 Aug ‘25 2 months ago |
|
Alnylam Pharmaceuticals
ALNY
$60.4B
|
Buy
Maintained
| $450 |
2%
downside
| 1 | +9.5% |
0
%
| 1 Aug ‘25 2 months ago |
|
Agios Pharmaceuticals
AGIO
$2.36B
|
Buy
Maintained
| $65 |
60%
upside
| 2 | +4.2% |
0
%
| 28 Jul ‘25 2 months ago |
|
Rocket Pharmaceuticals
RCKT
$369M
|
Hold
Downgraded
| $4 |
17%
upside
| 1 | -21% |
0
%
| 25 Jul ‘25 2 months ago |
|
Gossamer Bio
GOSS
$522M
|
Buy
Initiated
| $11 |
382%
upside
| 1 | +68% |
0
%
| 14 Jul ‘25 3 months ago |
|